Tailoring Tyrosine Kinase Inhibitors to Fit the Lung Cancer Genome Ace myhomework myhomework writers acemywork

(1). Summary Efforts to uncover the genetic basis of cancer have led to the understanding of the importance of critical key tumour suppressors and oncogenes. Additionally, numerous mutations that still need to be characterised have also been uncovered. The marked variations in the mutational profiles however point to every tumor being a distinct state that can be effectively treated with precise targeting of the specific combination of genetic changes that are unique to the tumor.